BNP Paribas Reiterates Outperform on Versigent, Lowers Price Target to $54

Benzinga · 2d ago
BNP Paribas analyst James Picariello reiterates Versigent (NYSE:VGNT) with a Outperform and lowers the price target from $55 to $54.